Potential protective effects of antihypertensive treatments during the Covid-19 pandemic: from inhibitors of the renin-angiotensin system to beta-adrenergic receptor blockers

被引：12
|
作者：
Kjeldsen, Sverre E. [1 ,2 ]
Narkiewicz, Krzysztof [3 ]
Burnier, Michel [4 ]
Oparil, Suzanne [5 ]
机构：
[1] Univ Oslo, Ullevaal Hosp, Dept Cardiol, Oslo, Norway
[2] Univ Oslo, Ullevaal Hosp, Dept Nephrol, Oslo, Norway
[3] Med Univ Gdansk, Dept Hypertens & Diabetol, Gdansk, Poland
[4] CHU Vaudois, Serv Nephrol & Hypertens, Lausanne, Switzerland
[5] Univ Alabama Birmingham, Vasc Biol & Hypertens Program, Dept Med, Birmingham, AL USA
来源：
BLOOD PRESSURE | 2021年 / 30卷 / 01期
关键词：
DRUGS;
D O I：
10.1080/08037051.2021.1862483
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：1 / 3
页数：3
相关论文
共 50 条
  • [31] Renin-Angiotensin System Inhibitors and COVID-19: Potential Therapeutics Rather Than Perpetrators
    Wang, Tzung-Dau
    ACTA CARDIOLOGICA SINICA, 2020, 36 (03) : 179 - 182
  • [32] Prescription of renin-angiotensin system inhibitors in Japan during the COVID-19 pandemic: interrupted time series study
    Miura, Ryosuke
    Okada, Kouji
    HYPERTENSION RESEARCH, 2023, 46 (12) : 2593 - 2602
  • [33] Prescription of renin-angiotensin system inhibitors in Japan during the COVID-19 pandemic: interrupted time series study
    Ryosuke Miura
    Kouji Okada
    Hypertension Research, 2023, 46 : 2593 - 2602
  • [34] Long-term effects of discontinuing renin-angiotensin system inhibitors in COVID-19
    Theurl, Fabian
    Sappler, Nikolay
    Rizas, Konstantinos D.
    Massberg, Steffen
    Bauer, Axel
    Schreinlechner, Michael
    RESPIROLOGY, 2022, 27 (09) : 788 - 790
  • [35] DGK Statement on COVID-19 and Treatment with Inhibitors of the Renin-Angiotensin System
    不详
    HAUTARZT, 2020, 71 (08): : 606 - 606
  • [36] Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19
    Kow, Chia Siang
    Zaidi, Syed Tabish Razi
    Hasan, Syed Shahzad
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020, 20 (03) : 217 - 221
  • [37] Renin-Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID-19
    Loader, Jordan
    Lampa, Erik
    Gustafsson, Stefan
    Cars, Thomas
    Sundstrom, Johan
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (15):
  • [38] Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19
    Chia Siang Kow
    Syed Tabish Razi Zaidi
    Syed Shahzad Hasan
    American Journal of Cardiovascular Drugs, 2020, 20 : 217 - 221
  • [39] Association between renin-angiotensin system inhibitors and COVID-19 complications
    Liabeuf, Sophie
    Moragny, Julien
    Bennis, Youssef
    Batteux, Benjamin
    Brochot, Etienne
    Schmit, Jean Luc
    Lanoix, Jean-Philippe
    Andrejak, Claire
    Ganry, Olivier
    Slama, Michel
    Maizel, Julien
    Mahjoub, Yazine
    Masmoudi, Kamel
    Gras-Champel, Valerie
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (05) : 426 - 434
  • [40] Possible Protective Effect of Renin-Angiotensin System Inhibitors in COVID-19 Induced Acute Kidney Injury
    Kow, Chia Siang
    Hasan, Syed Shahzad
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (08): : 1917 - 1918
12345